selegiline-N-oxide

structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Igarashi, Kazuo: 1 article (10/2004)
2.	Kasuya, Fumiyo: 1 article (10/2004)
3.	Katagi, Munehiro: 1 article (10/2004)
4.	Nishikawa, Mayumi: 1 article (10/2004)
5.	Tsuchihashi, Hitoshi: 1 article (10/2004)
6.	Tsutsumi, Hiroe: 1 article (10/2004)

1.	Parkinson Disease (Parkinson's Disease) 10/01/2004 - "In order to investigate the conversion of selegiline (SG), a drug used in the treatment of Parkinson's disease, to selegiline N-oxide (SGO) as a major metabolic pathway for SG, rat liver microsomal incubations were carried out in vitro in the presence of NADPH. "